Core Memory

Pedro Franceschi taught himself to code when he was eight years old. At 12, he began receiving legal notices from Apple, asking him to stop hacking iPhones. By 14, he was making hundreds of thousands of dollars a year selling software and had his mom accompanying him on job interviews in his home city of Rio de Janeiro. Even among coding and hacking prodigies, Franceschi stands out.Today, Franceschi is the co-founder and CEO of Brex, a financial technology company that was just acquired by Capital One for $5.15 billion. Franceschi is all of 29 years old now, so he’s done alright.Brex led a new wave of companies that brought more modern financial tools first to start-ups and then to businesses of all sizes. Over the years, it’s had some ups and downs, and Franceschi has been remarkably open about Brex’s stumbles, his mental health struggles and about the areas where he thinks Brex got things very right.Franceschi remains a hacker at heart and has been experimenting away with AI agents. He, in fact, says he’s running Brex – and his life – with a team of AI agents that read his e-mails and Slack messages, perform job recruiting tasks and schedule his day-to-day activities.We get into all of this on the episode, charting Franceschi’s rise from hacking phenom to running a multi-billion-dollar company and discussing where he thinks AI and money are heading.Do we have journalistic conflicts with this episode? Yes, we do. Brex has been the top sponsor of our podcast and video series. You can learn more about the depths of our relationship and what Brex can do for your business right here.The podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

Baiju Bhatt is trying to pull an Elon Musk.About 25 years ago, Musk sold his finance tech company PayPal and left dot-com life to get into rockets with the founding of SpaceX. Hardly anyone considered this a rational choice on Musk’s part. Space, after all, was where rich people went to blow their fortunes and fail.For his part, Bhatt co-founded the investing service Robinhood in 2013 and has now decided to get into the space business as well via a start-up called Aetherflux. The company aims to build a network of solar panel-packed satellites that suck up sunshine and then beam it down to Earth via infrared lasers. Yes. Actual space lasers. What could go wrong?The lasers would feed antennas and ground stations on Earth with energy. In theory, you could then direct power just about anywhere without needing to build a ton of infrastructure on the ground. Army convoys, data centers, etc. could just have electricity sent to them in remote areas.Bhatt explains all of this in the episode and gets deep into his personal story. He also recounts starting and running Robinhood through its ups and downs, including being both beloved and despised.Will the space lasers work? I dunno. It’s a lot. But we are fully in the era of trying new, bold ideas in Low Earth Orbit, and, well, I wrote a book predicting this very thing, and so am very much here for it.The Core Memory podcast is on all major platforms and on our YouTube channel over here. If you enjoy the show, please leave a review and tell your friends.This podcast is sponsored by Brex, the intelligent finance platform built to help companies spend smarter and move faster.We run on Brex and so should you. Learn more about Brex right here.The podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

We have tracked down the man and dog of the hour.Paul Conyngham and his dog Rosie gained worldwide attention over the past week for breaking new medical ground. Using a variety of artificial intelligence tools, Conyngham – and some doctors and scientists in Australia – managed to create a personalized (petalized?) cancer treatment for Rosie that appears to be working.The story resonated with the public for a couple of big reasons. First off, Conyngham has no real science or biology background. He’s a longtime AI researcher who used things like ChatGPT, Gemini and Grok to give him a plan for how to attack Rosie’s untreatable cancer and then how to craft and shape a unique mRNA shot for his pup. This exercise demonstrated the powers of AI technology to aid all of us with extra knowledge and skills and just how far bio-tech has come in terms of new cancer therapies.Most people have had their hearts warmed by the tale of Paul and Rosie. Dude’s dog is dying. Dude goes to great lengths to try and solve the problem. Dude and his dog seem to mark a major moment for AI and medicine.Some other people on the internet, however, are less excited by the story. They argue that the AI tools did very little here and that the science isn’t terribly conclusive or ground-breaking. Companies like Moderna and BioNTech already have personalized cancer vaccine data in trials, and it looks good. Who cares if we did the same thing for a dog? Rosie has also been treated with chemotherapy drugs, so we don’t even know if the mRNA technology is really the thing shrinking her tumors. And so on.You can find some of the major criticisms here and here.Some of the pushback may be valid, although Conyngham isn’t having it – as you’ll hear in the episode. It also sort of misses the point of this story.After talking to Conyngham, it’s clear enough to me that he used AI in some profound ways here and that what was done with Rosie is symbolic of a huge shift in medicine. Regulators better get ready because the tools now exist for people to do rather daring experimentation on their pets and themselves. People in dire circumstances and with some means are going to be pushing the boundaries of what’s possible on a regular basis. Paul and Rosie hit a nerve because their journey bundled up some massive technological and societal shifts into a tidy narrative.Anyway, come listen to Paul and have a peek at Rosie.The Core Memory podcast is on all major platforms and on our YouTube channel over here. If you enjoy the show, please leave a review and tell your friends.This podcast is sponsored by Brex, the intelligent finance platform built to help companies spend smarter and move faster.We run on Brex and so should you. Learn more about Brex right here.The podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

The mainstream media says almost nothing about induced pluripotent stem cells (iPSCs). So, you’re lucky that we’re here to help.These cells with a clunky name hold the promise of being able to reverse the aging process across our bodies. Put rather bluntly, your old, wine-soaked liver could become like your twenty-something, Jell-O-shot-soaked liver. Your aging neurons could fire like they once did. And your tired heart could be fresh and loving again.Billions of dollars have been funneled toward trying to figure out how to push iPSCs into our organs safely and effectively. We have not cracked the code yet, but there are signs that scientists are getting closer.Nabiha Saklayen, the co-founder and CEO of Cellino Bio, is an iPSC whiz and joined the podcast this week to bring us all up to speed on the technology. She covers how iPSCs work, their history and the state of iPSC treatments around the world.Her company is trying to take iPSCs, which have largely been made by hand, and mass produce them to accelerate experimentation and hopefully therapies and to reduce costs around this fascinating technology.The Core Memory podcast is on all major platforms and on our YouTube channel over here. If you enjoy the show, please leave a review and tell your friends.This podcast is sponsored by Brex, the intelligent finance platform built to help companies spend smarter and move faster.We run on Brex and so should you. Learn more about Brex right here.The podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

Will Wilson paints a bleak picture for where we’re heading with code written by AIs.He thinks the world will fill with poorly written code that no one understands and that software bugs will proliferate through critical systems. Your airplane that has gotten safer and safer with each passing decade will be running on code that no one has really checked all that well. Which would be bad.What’s more, Wilson fears that humans will lose their software writing skills over time as AI takes on more and more tasks. We’ll become dumber as a whole. Which would also be bad.Wilson is a mathematician turned start-up founder who built the company Antithesis in a bid to modernize software testing techniques and help humans write better code.In this episode, we get into his life story, his fears around AI software and what he thinks we should do to make massive improvements to the code that underlies everything.The Core Memory podcast is on all major platforms and on our YouTube channel over here. If you enjoy the show, please leave a review and tell your friends.This podcast is sponsored by Brex, the intelligent finance platform built to help companies spend smarter and move faster.We run on Brex and so should you. Learn more about Brex right here.The podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

Anna Prouse has survived multiple assassination attempts. She’s been tapped by General David Petraeus to get work done in Iraq that U.S. troops couldn’t handle. She’s faced off against Iranian militants. Over a multi-decade career working in the Middle East, Prouse earned the rarest of titles – “Honorary Man” – because of her ability to thrive and hold positions of authority in a hyper-masculine society.(If you can’t tell, we’re going a little off schedule with this week’s podcast. I heard about Prouse’s story from a friend and had no choice but to have her on the show.)Born in Italy, Prouse is a former journalist who ended up in Iraq in 2003 and went to work trying to rebuild the country’s health infrastructure first for the Red Cross and then on behalf of the U.S. government. She lived in constant danger for many years and proved adept at moving between the U.S., Iraqi and Iranian powers because of her unique approach to problem-solving.More recently, Prouse has worked in Silicon Valley, including a stint at Google where she found complaints from the workforce about the quality of the quinoa and sushi quite comical.As if her career was not dramatic enough, Prouse also survived a brain tumor during what were meant to be her easier years.We discuss all of this in the show, using Prouse’s best-selling memoir as a guide through her journey.The Core Memory podcast is on all major platforms and on our YouTube channel over here. If you enjoy the show, please leave a review and tell your friends.This podcast is sponsored by Brex, the intelligent finance platform built to help companies spend smarter and move faster.We run on Brex and so should you. Learn more about Brex right here.The podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups.' This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

Ed Boyden has spent the last twenty or so years building the technology needed to create a working simulation of living systems. Put another way – he’s been trying to turn biology into physics.Boyden has helped develop new techniques for imaging the brain and the body, including optogenetics and expansion microscopy. He’s also known for nurturing all-star talent at his lab at MIT and he and his students have gone on to form numerous bio-tech start-ups. Overall, Boyden is regarded as one of the top scientific minds of this era.It was a genuine honor to have Boyden on the show, and we’re sure you’ll enjoy this episode. In this episode, filmed at Boyden’s office, we discuss his background as a child prodigy, his work and what it might actually mean to engineer something like a mind or consciousness. We also get into Boyden’s skepticism around current large language models and the state of science funding in the U.S.The Core Memory podcast is on all major platforms and on our YouTube channel over here. If you enjoy the show, please leave a review and tell your friends.This podcast is sponsored by Brex, the intelligent finance platform built to help companies spend smarter and move faster.We run on Brex and so should you. Learn more about Brex right here.The podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

We do not usually do venture capitalists on the Core Memory podcast. They can be a lot and like to hear themselves talk a bit too much. (Not you! The other ones – Ed.)But, for Peter Barrett, we will always make an exception. He’s a general partner at Playground Global and is one of those people who knows an awful lot about an awful lot of things. He is one of my favorite people to listen to and gets my mind racing with tons of new ideas every time we speak. Self-taught, Peter spent the early part of his career as a force of nature in the software industry. He was visited by the Men In Black as a teenager. He helped start Rocket Science Games, which was the hottest video game maker in town before it wasn’t. While there, Peter happened to employ a young intern named Elon Musk. . .Later, Peter would be part of the team that created WebTV and a longtime distinguished engineer at Microsoft, working alongside Bill Gates and Steve Ballmer.These days Peter goes deep on deep tech at Playground. As such, we talk quantum computing, the insane world of AI agents, nuclear power, data centers in space (and why they won’t work) and whether or not humans should be in total panic.The Core Memory podcast is on all major platforms and on our YouTube channel over here. If you enjoy the show, please leave a review and tell your friends.This podcast is sponsored by Brex, the intelligent finance platform built to help companies spend smarter and move faster.We run on Brex and so should you. Learn more about Brex right here.The podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

The center of the universe has been born again. The most insufferable posters on our timeline, including myself, are enjoying the abundance found in San Francisco thanks to the AI boom lining the pockets of fresh college dropouts. The themed parties are bumping, the LLMs look good, the La Croix is flowing. There is much doom in this world, but not in this podcast.On this episode of the Core Memory podcast, we’re joined by Jayden Clark. He’s the host of Members of Technical Staff, a podcast about niche San Francisco tech culture. He’s been featured in the New Yorker, The New York Times, and Business Insider. We discuss all the important parts of life in this new version of San Francisco: themed parties, online discourse, and the permanent underclass.The Core Memory podcast is on all major platforms and on our YouTube channel over here. If you enjoy the show, please leave a review and tell your friends.This podcast is sponsored by Brex, the intelligent finance platform built to help companies spend smarter and move faster.We run on Brex and so should you. Learn more about Brex right here.The podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

Let’s get right to the point: Nobel Prize winner Jennifer Doudna is on the pod this week.Doudna won the 2020 Nobel Prize in Chemistry alongside Emmanuelle Charpentier for their work developing “a method for high-precision genome editing.” They, and others, helped usher in the CRISPR revolution with people getting very, very excited about the prospects of editing genes in humans, animals, and plants with more precision and ease.There have been some massive recent CRISPR wins. Casgevy, which treats sickle cell disease, emerged as the first FDA-approved CRISPR therapy. And, last year, an infant in Pennsylvania had a rare disease treated with record-breaking speed via CRISPR technology.That said, CRISPR has, in many ways, not lived up to the hope and hype just yet. CRISPR therapies remain expensive and tough to distribute throughout the body.Doudna is convinced that several major CRISPR breakthroughs are upon us, and we get into where she sees the field going. We discuss the work she’s doing at start-ups and the Innovative Genomics Institute – a research powerhouse that links UC Berkeley, UC San Francisco, and UC Davis.And we talk about Pomona College, our shared alma mater, rejecting our wonderful, brilliant children who will no doubt go on to do amazing things in the world and likely make untold billions that will be donated to other tremendous institutions. JK. Chirp, chirp!If you want to get up to speed on gene editing’s present and future, you will not find a better discussion.The Core Memory podcast is on all major platforms and on our YouTube channel over here. If you enjoy the show, please leave a review and tell your friends.This podcast is sponsored by Brex, the intelligent finance platform built to help companies spend smarter and move faster.We run on Brex and so should you. Learn more about Brex right here.The podcast is also made possible by E1 Ventures, which backs the most ambitious founders (probably some peptide users) and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

On January 5th, famed AI researcher Jerry Tworek stunned world+dog by announcing his departure from OpenAI. A few days later, he hopped over to the Core Memory podcast studio for his not-so-formal exit interview.Tworek joined OpenAI in 2019 when the research lab was a research lab and had about thirty employees. He went on to work on many of OpenAI’s most consequential products, including the company’s reasoning technology, which ushered in a new era for the entire AI field. (Yes, Tworek worked on Q* before it was Strawberry before it was o1.)Both Kylie and I have been longtime Tworek fans. He’s smart, funny and never really sought the limelight despite his massive contributions.In the episode, Tworek reveals that he found it hard to keep doing high-risk, pioneering work at OpenAI as the company shifted toward what Tworek describes as more conservative ways. He, in fact, thinks the large AI companies have become conservative as a whole and that there might be bigger, better ideas to be found elsewhere. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

Biohacking has gone through a lot of different phases. Implanting an NFC chip in your hand is old school and having a blood boy is passé. Among Silicon Valley’s 20-somethings, all the cool kids have a peptide stack. Jasmine Sun joins us this week to chat about all things peptides. She was previously a product manager at Substack, but now she writes about San Francisco culture on her own Substack. Jasmine recently published a deep dive in The New York Times about the trendy injectable and deets on the Chinese peptide rave (which you first read about from our new writer, Kylie Robison, last month).If you want to be like Wolverine, don’t do drugs. Subscribe to our newsletter and podcast instead. Our words are made of adamantium.Do you feel old yet? We do. In this episode, we get into all the important bits: What are peptides, why are they Chinese, and how is RFK Jr. involved? This is not medical advice, but if you do inject some peptides after this episode, tag us.The Core Memory podcast is on all major platforms and on our YouTube channel over here. If you enjoy the show, please leave a review and tell your friends.Our show is sponsored by Brex. It builds finance tech that makes expensing and accounting for things like peptides super easy, if your company is cool with such things. Like thousands of ambitious, innovative companies, we run on Brex so we can spend smarter and move faster. And you can too. Learn more at www.brex.com/corememoryThe podcast is also made possible by E1 Ventures, which backs the most ambitious founders (probably some peptide users) and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

We have a guest host and some breaking news for this episode.Eryney Marrogi, the scientist and soon-to-be doctor who writes for us now and again, has taken over the pod studio to interview Richard Fuisz. Earlier today, Marrogi broke a story on Fuisz’s company Nonfiction Labs, which has developed technology that could make it possible to use magnets to better control how cancer therapies are doled out in the body.The two big brains get into Nonfiction’s technology and into Fuisz’s rather prolific work at the cutting-edge of the biotech field. The conversation goes into how biotech actually gets built, competition with China and Fuisz’s family legacy of invention (his grandfather was the prolific inventor featured in “Bad Blood”).The Core Memory podcast is on all major platforms and on our YouTube channel over here. If you enjoy the show, please leave a review and tell your friends. Our show is sponsored by Brex, the intelligent finance platform. Like thousands of ambitious, innovative companies, we run on Brex so we can spend smarter and move faster. And you can too. Learn more at www.brex.com/corememoryThe podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

We have been talking about computer-aided drug discovery for well more than a decade. It used to be the case that start-ups pitched their ability to use “machine learning” to hunt for new, promising therapies. Now we call machine learning “artificial intelligence” and have a new class of start-ups claiming big science breakthroughs.One of these new wave start-ups is Chai Discovery and its founders Josh Meier and Jack Dent join the podcast this week. (The Core Memory podcast is available on all major platforms and on our YouTube pod channel.) The company was founded in 2024 and is backed by OpenAI, Menlo Ventures+Anthropic, Thrive and others. (Chai is already a unicorn.) It published a number of notable accomplishments this last year, including using its own AI model to churn out promising antibody designs at an unprecedented clip.The first couple iterations of machine learning-aided drug discovery companies came and went without tremendous success. Chai and Nabla Bio are two of the buzziest members of this new era of AI companies. Their models really do seem to be harnessing the advances in AI to hit on potential drug targets and designs in rather profound ways. Bio-tech, in fact, seems like the place where AI may make the most stunning scientific advances first.In this episode, we get into Chai’s intellectual roots as a research project within Facebook/Meta and how the company has gone after building its models. We also try to provide a realistic picture of the current state of AI drug discovery.The implications of the work done by Chai, Nabla and others are far reaching. If we’re able to come up with new drug designs at this accelerated rate, we will need major changes around how drugs are tested and put through trials. The current drug testing and FDA approval system is simply not set up to move as quickly as bio-tech appears to be going.This will be our last episode for the year, and we’re taking a tiny break between posting the next one as the Core Memory crew has a little time off. Thank you so, so much to all of you who have listened to the show in our first year. We hope you’ve enjoyed it and learned some things along the way.Our show is sponsored by Brex, the intelligent finance platform. Like thousands of ambitious, innovative companies, we run on Brex so we can spend smarter and move faster. And you can too. Learn more at www.brex.com/corememoryThe podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

Well, here we are. It’s brain uploading time.As we’ve just reported, famed neuroscientist Sebastian Seung has created a new start-up called Memazing. The company has set out to build digital brains in software that are based upon the maps of animal brains. Memazing is, in effect, seeking to reverse engineer how animal brains work and to use this information to bring to life a new form of computerized intelligence.This work could lead to, say, more energy efficient AI systems that are modeled on real brains. It could help with aligning AI systems with human intelligence. And it could be a major step toward creating emulations of full human brains and perhaps, one day, making minds uploadable.We get into all of this with Seung on this week’s podcast. We also explore his decades of neuroscience work dedicated to building connectomes, or ultra-detailed schematics of animal brains and all their neurons and synapses.Seung is brilliant and fascinating. Listen and/or watch for yourself.The Core Memory podcast is available on all major platforms and our YouTube channel. Our show is sponsored by Brex, the intelligent finance platform. Like thousands of ambitious, innovative companies, we run on Brex so we can spend smarter and move faster. And you can too. Learn more at www.brex.com/corememoryThe podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

Jake Becraft was working on mRNA way before it was cool.In fact, Becraft’s advisors at MIT told him trying to develop therapies with mRNA would be a colossal waste of time. But, here we are in 2025, and Becraft has pushed the mRNA technology that gained so much attention during the pandemic in rather incredible new directions.Becraft joins the podcast this week to talk about his company Strand Therapeutics and its programmable mRNA technology. Strand has developed a way to send therapies into the body and have them aim right for diseased cells. Its first clinical trial has focused on melanoma where Strand has been able to treat patients who were deemed incurable with any other medicines.Jake and I met up at Strand’s headquarters in Boston with a double-helix hanging over our heads. We covered Strand’s work, Jake’s background and the future of synthetic biology.We’ll have a video episode coming on Strand and its lab and technology soon on our YouTube channel, which you should be subscribing to because it’s awesome.Our show is sponsored by Brex, the intelligent finance platform. Like thousands of ambitious, innovative companies, we run on Brex so we can spend smarter and move faster. And you can too. Learn more at www.brex.com/corememoryThe podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

America has a new steel company, which is sort of a weird thing to write in 2025.It’s called Hertha Metals, and it’s based in Houston. It’s also run by a woman named Laureen Meroueh, who is this week’s guest. As far as we can tell, Meroueh stands out as the first female to start and run a steel producer.Meroueh grew up as something of a child prodigy in Florida and went on to earn a PhD in mechanical engineering from MIT. She then invented some of the processes that make Hertha different from traditional steel producers.Hertha relies on natural gas and hydrogen instead of coal to make high-grade steel. Its process is potentially cleaner, simpler and cheaper than the approaches used by the traditional steelmakers that have been around for more than 150 years. The start-up is already producing one ton of steel per day and is now looking to prove that it can make much, much more and compete head-to-head against the major steel players.In this episode, we get into how Hertha’s process works, the steel industry overall, why the U.S. needs this type of technology and how Meroueh ended up as a steel magnate.Our show is sponsored by Brex, the intelligent finance platform. Like thousands of ambitious, innovative companies, we run on Brex so we can spend smarter and move faster. And you can too. Learn more at www.brex.com/corememoryThe podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

One must not feel sorry for Mark Chen. He gets paid very well to work in one of the most exciting fields imaginable.That said, as OpenAI’s Chief Research Officer, he has the difficult job of picking the company’s research priorities and of dealing with OpenAI’s employees begging him for more, more, more GPUs to power their work. This is a hectic gig, and, if you believe that AI will do all the things that AI companies promise it will do, then an awful lot of pressure and expectation is on Chen’s shoulders.We recently spent almost two hours with Chen talking about his job, his background and his fierce competitive streak. (I’ve seen the man play poker. He takes it very seriously. He’s also proven willing to counter Mark Zuckerberg’s personal soup deliveries to AI researchers in order to court and retain talent.) And, of course, we got into the future of AI.This conversation took place just a couple of days after Google released Gemini 3, and we spent some time on how OpenAI plans to counter this new, powerful model.We think you’ll get to learn a lot more about Chen’s personality and motivations in this episode. Enjoy!Our show is sponsored by Brex, the intelligent finance platform. Like thousands of ambitious, innovative companies, we run on Brex so we can spend smarter and move faster. And you can too. Learn more at www.brex.com/corememoryThe podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

Pablos Holman has one of the most-watched TED Talks of all time, and that’s sort of the least interesting thing about him.For the past 30 years or so, Holman has been traveling amid the most inventive and eccentric tech circles. He grew up in the wilds of Alaska and turned into a hacker extraordinaire. He helped start the rocket company Blue Origin with Jeff Bezos and sci-fi author Neal Stephenson. And he helped Bill Gates, Nathan Myhrvold, and Edward Jung create an invention factory at Intellectual Ventures.If you like our stories, videos and podcasts, please do subscribe. All of this stuff takes a team to produce, and we could use your support.These days, Holman is running a venture capital firm that scours the world for the biggest ideas from wild-eyed inventors missed by others. He published a book this year that captures some of his thoughts on invention and where our civilization is heading.In this episode, we dive into the book, Holman’s bizarre career and the future of science and research and development. I think you will be surprised and entertained.Our show is sponsored by Brex, the intelligent finance platform. Like thousands of ambitious, innovative companies, we run on Brex so we can spend smarter and move faster. And you can too. Learn more at www.brex.com/corememoryThe podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

In December of 2024, the Chinese start-up DeepSeek shocked the world with the release of an AI model that appeared much cheaper to make and run than those from its American rivals. The company also open sourced its AI, meaning it released the blueprints of its model to the public.Our guest this week is Misha Laskin. His start-up Reflection AI looks to be the prime counterweight to DeepSeek and a host of other open source Chinese models. Laskin argues that open source models can be just as good as the models developed by the likes of OpenAI, Google and Anthropic and that the West needs this to be the case.Reflection has raised $2 billion and is valued at $8 billion, although the figures in AI have become so lofty as to almost feel meaningless at this point. That said, the company was able to raise so much money because of the pedigree of its team with a number of engineers, like Laskin, coming from DeepMind.I have, in full confession, not been paying enough attention to open source models and the ways in which the Chinese models seem to have become the basis for a lot of corporate work in the US. Laskin dug in deep on this topic, and hopefully you’ll feel more up to speed after listening to the episode.You can find the Core Memory podcast on all major platforms and on our YouTube channel. Enjoy!Our show is sponsored by Brex, the intelligent finance platform. Like thousands of ambitious, innovative companies, we run on Brex so we can spend smarter and move faster. And you can too. Learn more at www.brex.com/corememoryThe podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

Well, I wrote a book and made a movie about this week’s guest, so he must be fascinating. (Otherwise, I wasted six years of my life.)Will Marshall has done things beyond supplying me with material. He’s the co-founder and CEO of Planet Labs. For those who don’t know, Planet changed the aerospace industry forever by lowering the cost of satellites and proving that they could be mass produced. It has surrounded the Earth with hundreds of satellites that photograph and analyze all our planet’s landmass every day.Go on. Sign up. We bring you these people for free. Help us, help you. In this episode, we get into Planet’s history, what these satellites do and why they’re so important.Marshall is a deep thinker on many areas and has lived in an unconventional manner. So we also get into much, much more, including the communal house scene in the Bay Area, what Marshall sees as the three major shifts that will occur over the next decade and how he balances his idealism with being a capitalist.In conclusion, Marshall is fascinating. I did not waste six years of my life. And When The Heavens Went on Sale makes for a great Christmas present.Seriously. Let’s make the world smarter.Our show is sponsored by Brex, the intelligent finance platform. Like thousands of ambitious, innovative companies, we run on Brex so we can spend smarter and move faster. And you can too. Learn more at www.brex.com/corememoryThe podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

Over the past week or so, Elon Musk has started hyping up the launch of the long-, long-awaited Tesla Roadster 2.Musk appeared on the Joe Rogan podcast last week and said he hoped to unveil the car before the end of the year. (When it goes on sale is another story.) He suggested the car might fly. (Okay?) And he said that it would almost certainly be the most memorable launch of any product in history. Which is a very Musk thing to say and - also in keeping with Musk - possibly true.At the Tesla shareholder meeting today, Musk again promised to wow with the Roadster 2 unveiling. This promise came in response to a shareholder who asked if he could, in fact, have the first Roadster 2 VIN. “Well, I guess it’s according to whoever put down their deposit in that sequence,” Musk said.Well, we are here with a special podcast to reveal exactly who stands to get the first Roadster 2 off the line – the investor Konstantin Othmer.I ran into Othmer rather by coincidence this week, and he happened to be holding the receipts that show he wrote the first Roadster 2 check for $200,000 back in 2013.This episode has some wonderful early Musk and Tesla tales plus the whole Roadster 2 backstory. Enjoy!Our show is sponsored by Brex, the intelligent finance platform. Like thousands of ambitious, innovative companies, we run on Brex so we can spend smarter and move faster. And you can too. Learn more at www.brex.com/corememoryThe podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

Joshua Steinman spent four years (2017-2021) working for President Trump and had a very broad remit. He shaped all cyber, telecommunications, cryptocurrency, and supply chain policy.It’s fair to say the Washington press corps did not adore Steinman. He was often portrayed as a young, brash Silicon Valley-type who bubbled over with ambition and lacked the usual political decorum.Despite how the press corps felt, Steinman did important work on several fronts. Before and during his time in Washington, he helped create deeper ties between the U.S. military and Silicon Valley in a bid to modernize the technology at the Defense Department’s disposal. He also sounded repeated alarms about how vulnerable the U.S. infrastructure is to cyber attacks, particularly those originating in China.These days Steinman runs Galvanick, a company aimed at hardening the technology infrastructure of industrial companies and operations.Steinman is opinionated and then some. In this episode, he will claim that Trump is among the smartest humans on Planet Earth. Some of you will be okay with this. Some of you will hate this. I look forward to your comments.Beyond Trump, we get into Steinman’s unusual career, the state of U.S. military technology and security, the cyber Cold War between the U.S. and China and a host of other light topics. Enjoy!The Core Memory podcast is available on all major platforms, including Apple, Spotify and YouTube. Our show is sponsored by Brex, the intelligent finance platform. Like thousands of ambitious, innovative companies, we run on Brex so we can spend smarter and move faster. And you can too. Learn more at www.brex.com/corememoryThe podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

Celine Halioua and her company Loyal are on track to deliver a drug next year that could help dogs live longer.Loyal’s therapy is aimed at senior dogs (10+ years of age) that weigh more than 14 pounds. It’s a pill that the dogs will take daily and that’s designed to extend the dogs’ lifespan by at least a year. To get to this point, Loyal conducted a massive clinical trial with 1,300 dogs, and the FDA has liked what it’s seen so far.Halioua joins the podcast this week to chat about her unique approach to cracking the longevity field.Loyal has been betting that it will be easier to prove that longevity drugs work (and get regulators on board) by starting with dogs instead of humans. The company has been testing promising longevity compounds and now has three therapies in its drug pipeline aimed at our canine friends.I’ve known Halioua for several years now. She’s one of the deepest, most pragmatic thinkers in the longevity field and approaches her work without the hype and false promises that often accompany some of our live forever gurus.We get into her life, her work, some of the oddities of running a company in San Francisco and what it’s like to be in bio-tech during the great AI hype era.Enjoy!The Core Memory podcast is sponsored by Brex, the intelligent finance platform. Like thousands of ambitious, innovative companies, we run on Brex so we can spend smarter and move faster. And you can too. Learn more at www.brex.com/corememoryThe podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe